Skip to main content

Familial Hypocalciuric Hypercalcemia

  • Chapter
  • First Online:
Hyperparathyroidism

Abstract

Persistent primary hyperparathyroidism (PHPT) after an initial neck exploration requires a consideration of several factors including the adequacy of the initial neck exploration, as well as reviewing the underlying diagnosis. In the setting of a possible familial disorder, initial biochemical screening with a finding of a low urinary calcium to creatinine clearance ratio would suggest familial hypocalciuric hypercalcemia (FHH). Genetic testing of the CASR gene is available and is helpful in such clinical situations as there is an overlap in the biochemical appearance of PHPT and FHH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thakker RV, Familial and hereditary forms of primary hyperparathyroidism. In: Bilezikian JP, editor. The parathyroids. Elsevier; 2015. p. 341–88.

    Google Scholar 

  2. Law Jr WM, Heath 3rd H. Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med. 1985;102(4):511–9.

    Article  PubMed  Google Scholar 

  3. Marx SJ, et al. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine. 1981;60(6):397–412.

    Article  PubMed  CAS  Google Scholar 

  4. Ward BK, et al. The role of the calcium-sensing receptor in human disease. Clin Biochem. 2012;45(12):943–53.

    Article  PubMed  CAS  Google Scholar 

  5. Nesbit MA, et al. Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia. N Engl J Med. 2013;368(26):2476–86.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Nesbit MA, et al. Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet. 2013;45(1):93–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Christensen SE, et al. Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes. 2011;18(6):359–70.

    Article  PubMed  CAS  Google Scholar 

  8. Isaksen T, et al. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcif Tissue Int. 2011;89(4):285–94.

    Article  PubMed  CAS  Google Scholar 

  9. Kifor O, et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab. 2003;88(1):60–72.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

All authors state that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ann E. Kearns MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Mayo Foundation for Medical Education and Research

About this chapter

Cite this chapter

Kearns, A.E., Wermers, R.A. (2016). Familial Hypocalciuric Hypercalcemia. In: Kearns, A., Wermers, R. (eds) Hyperparathyroidism. Springer, Cham. https://doi.org/10.1007/978-3-319-25880-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-25880-5_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-25878-2

  • Online ISBN: 978-3-319-25880-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics